biotech primer logo
Biosimilars: Ready or Not, Here They Come

Biosimilars: Ready or Not, Here They Come

by | Jan 15, 2015 | Regulation

Last week, the FDA’s Oncologic Drugs Advisory Committee unanimously recommended Novartis’  biosimilar version of Amgen’s megahit Neupogen (filgrastim), effectively paving the way for the first US biosimilar approval in the near future. Filgrastim is a...